Camereyes
Camereyes
Agent26Agent Readiness: 26/100. Bottom 25%. Measured by StartupHub.ai. Median 41.AI-powered diagnostic imaging for early detection of diabetic retinopathy.
About
Camereyes developed an AI-powered platform for early diagnosis and management of diabetic retinopathy, a leading cause of blindness. Their technology aimed to analyze retinal images to identify early signs of the disease, enabling timely intervention and preventing vision loss.
Competitors & alternatives (6)
Camereyes alternatives 
Key facts
At-a-glance profile data
- Website
- camereyes.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2015
- Employees
- 1
- Total funding
- $700K
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 30 Nov 2015 | Undisclosed round | $700K | - |
Tech stack
Detected on camereyes.com, last scanned 24 May 2026. Run your own scan
- Hosting
- AWS
Add first review
Frequently asked
How much funding has Camereyes raised?
Camereyes has raised a total of $700K in funding.
How many employees does Camereyes have?
Camereyes has approximately 1 people on record.
What is Camereyes's current status?
Camereyes's current operating status is: Inactive.